GSK plc (GLAXF) Stock Overview
Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.
GSK plc (GLAXF)
Key Financials
Key Financials
Market Cap
100.7B
P/E Ratio
14.13
EPS (TTM)
$1.90
ROE
0.33%
GLAXF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GSK plc (GLAXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.30.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.13 and a market capitalization of 100.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.